chronic GvHD

SILVER SPRING, Maryland, June 30, 2026 The U.S. Food and Drug Administration (FDA) has approved Tregzi, the first regulatory...

SILVER SPRING, Maryland, June 30, 2026 The U.S. Food and Drug Administration (FDA) has approved Tregzi, developed by Orca...

MENLO PARK, Calif., June 30, 2026 Orca Bio announced that the U.S. Food and Drug Administration (FDA) has approved...

INCHEON, South Korea, July 1, 2026 Samsung Bioepis has officially announced the U.S. relaunch of BYOOVIZ® (ranibizumab-nuna), the first...

SILVER SPRING, Md., June 30, 2026 The U.S. Food and Drug Administration (FDA) has approved Tregzi, the first regulatory...

Singapore | May 4, 2026 Specialised Therapeutics has announced that NIKTIMVO® (axatilimab) has received regulatory approval from the Therapeutic...

PARIS, France, March 31, 2026 Sanofi has received European Commission approval for Rezurock® (belumosudil) for the treatment of chronic...